TNSN96069A1 - Un procede pour la preparation de l'hydrochlorure de lercanidipine - Google Patents

Un procede pour la preparation de l'hydrochlorure de lercanidipine

Info

Publication number
TNSN96069A1
TNSN96069A1 TNTNSN96069A TNSN96069A TNSN96069A1 TN SN96069 A1 TNSN96069 A1 TN SN96069A1 TN TNSN96069 A TNTNSN96069 A TN TNSN96069A TN SN96069 A TNSN96069 A TN SN96069A TN SN96069 A1 TNSN96069 A1 TN SN96069A1
Authority
TN
Tunisia
Prior art keywords
dimethyl
preparation
diphenylpropyl
nitrophenyl
lercanidipine hydrochloride
Prior art date
Application number
TNTNSN96069A
Other languages
English (en)
French (fr)
Inventor
Leonardi Amedeo
Motta Gianni
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of TNSN96069A1 publication Critical patent/TNSN96069A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TNTNSN96069A 1995-05-12 1996-05-10 Un procede pour la preparation de l'hydrochlorure de lercanidipine TNSN96069A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI950957A IT1274480B (it) 1995-05-12 1995-05-12 Procedimento migliorato per la preparazione della lercanidipina cloridrato

Publications (1)

Publication Number Publication Date
TNSN96069A1 true TNSN96069A1 (fr) 2005-03-15

Family

ID=11371581

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN96069A TNSN96069A1 (fr) 1995-05-12 1996-05-10 Un procede pour la preparation de l'hydrochlorure de lercanidipine

Country Status (37)

Country Link
EP (1) EP0824517B1 (enExample)
JP (1) JP4038622B2 (enExample)
KR (1) KR100395441B1 (enExample)
CN (1) CN1101810C (enExample)
AR (1) AR002739A1 (enExample)
AT (1) ATE221050T1 (enExample)
AU (1) AU694046B2 (enExample)
BG (1) BG62400B1 (enExample)
BR (1) BR9608374A (enExample)
CA (1) CA2217849C (enExample)
CZ (1) CZ288634B6 (enExample)
DE (1) DE69622552T2 (enExample)
DK (1) DK0824517T3 (enExample)
DZ (1) DZ2032A1 (enExample)
EA (1) EA000346B1 (enExample)
EE (1) EE03351B1 (enExample)
EG (1) EG21755A (enExample)
ES (1) ES2179942T3 (enExample)
HU (1) HU226709B1 (enExample)
IL (1) IL118143A (enExample)
IN (1) IN188486B (enExample)
IT (1) IT1274480B (enExample)
MA (1) MA23858A1 (enExample)
MX (1) MX9708662A (enExample)
MY (1) MY113802A (enExample)
NO (1) NO309423B1 (enExample)
NZ (1) NZ309059A (enExample)
PL (1) PL185260B1 (enExample)
PT (1) PT824517E (enExample)
RO (1) RO119616B1 (enExample)
SA (1) SA96170216B1 (enExample)
SK (1) SK283321B6 (enExample)
TN (1) TNSN96069A1 (enExample)
TW (1) TW404940B (enExample)
UA (1) UA46769C2 (enExample)
WO (1) WO1996035668A1 (enExample)
ZA (1) ZA963716B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852737B2 (en) 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
ITMI20011726A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
WO2004035051A1 (en) * 2002-10-16 2004-04-29 Recordati Ireland Limited Lisinopril/lercanidipine combination therapy
AR052918A1 (es) * 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
KR100713136B1 (ko) * 2005-05-04 2007-05-02 주식회사 대희화학 무수 레르카니디핀 염화수소 결정다형의 개선된 신규결정화 방법
DE602005017199D1 (de) 2005-06-15 2009-11-26 Hetero Drugs Ltd Neues verfahren zur herstellung von lercanidipin
EP1940790B1 (en) 2005-09-16 2015-09-02 Glenmark Pharmaceuticals Limited Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
KR100811497B1 (ko) * 2005-10-19 2008-03-07 신풍제약주식회사 무수 염산 1,4-디하이드로피리딘 유도체의 제조 방법
DE602006003877D1 (de) * 2006-05-24 2009-01-08 Cf Pharma Ltd Verfahren zur Herstellung von Lercanipidin
KR100808281B1 (ko) * 2006-06-30 2008-03-03 주식회사 하원정밀화학 레르카니디핀 및 그 산부가염의 제조방법
CN102020602B (zh) * 2009-09-18 2013-12-25 深圳信立泰药业股份有限公司 盐酸乐卡地平晶型及其制备方法和含有该晶型的药物组合物
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
SI2654729T1 (sl) 2010-12-24 2016-08-31 Krka, D.D., Novo Mesto Homogene farmacevtske oralne dozirne oblike, ki obsegajo lerkanidipin in enalapril ali njune farmacevtsko sprejemljive soli skupaj z organsko kislino
CN102516160B (zh) * 2011-12-16 2014-04-02 华润赛科药业有限责任公司 一种高纯盐酸乐卡地平的合成工艺
CN102558032B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 一种无定形盐酸乐卡地平及其制备方法
CN102584682A (zh) * 2011-12-31 2012-07-18 苏州二叶制药有限公司 盐酸乐卡地平的制备方法
CN109956943B (zh) * 2019-04-18 2021-07-20 合肥合源药业有限公司 一种二氢吡啶类药物中脱羧缩合杂质及其制备、控制方法
CN117945985A (zh) * 2024-01-12 2024-04-30 福安药业集团重庆博圣制药有限公司 盐酸乐卡地平的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters

Also Published As

Publication number Publication date
AU694046B2 (en) 1998-07-09
AU5898596A (en) 1996-11-29
NZ309059A (en) 1998-10-28
EA199700374A1 (ru) 1998-10-29
IT1274480B (it) 1997-07-17
CA2217849C (en) 2007-09-11
IL118143A0 (en) 1996-09-12
DE69622552D1 (de) 2002-08-29
JPH11504932A (ja) 1999-05-11
EP0824517B1 (en) 2002-07-24
DK0824517T3 (da) 2002-11-18
SK151497A3 (en) 1998-05-06
HUP9801913A3 (en) 1999-01-28
SA96170216B1 (ar) 2005-12-21
EE03351B1 (et) 2001-02-15
ES2179942T3 (es) 2003-02-01
BR9608374A (pt) 1999-08-24
CZ288634B6 (cs) 2001-08-15
PL185260B1 (pl) 2003-04-30
EP0824517A1 (en) 1998-02-25
KR100395441B1 (ko) 2004-02-05
NO975176L (no) 1997-11-11
CN1101810C (zh) 2003-02-19
IN188486B (enExample) 2002-10-05
SK283321B6 (sk) 2003-06-03
CN1184468A (zh) 1998-06-10
NO309423B1 (no) 2001-01-29
UA46769C2 (uk) 2002-06-17
ITMI950957A1 (it) 1996-11-12
DE69622552T2 (de) 2003-01-23
EA000346B1 (ru) 1999-04-29
PL323236A1 (en) 1998-03-16
RO119616B1 (ro) 2005-01-28
CA2217849A1 (en) 1996-11-14
MY113802A (en) 2002-05-31
BG62400B1 (bg) 1999-10-29
ITMI950957A0 (it) 1995-05-12
HU226709B1 (en) 2009-07-28
ZA963716B (en) 1996-11-20
KR19990008378A (ko) 1999-01-25
MA23858A1 (fr) 1996-12-31
JP4038622B2 (ja) 2008-01-30
IL118143A (en) 2001-06-14
NO975176D0 (no) 1997-11-11
TW404940B (en) 2000-09-11
MX9708662A (es) 1998-08-30
BG102034A (en) 1998-04-30
AR002739A1 (es) 1998-04-29
WO1996035668A1 (en) 1996-11-14
EG21755A (en) 2002-02-27
ATE221050T1 (de) 2002-08-15
PT824517E (pt) 2002-12-31
CZ356797A3 (cs) 1998-04-15
HUP9801913A2 (hu) 1998-12-28
DZ2032A1 (fr) 2002-07-21

Similar Documents

Publication Publication Date Title
AR002739A1 (es) Un procedimiento para la preparacion de hidrocloruro de lercanidipino y el clorhidrato de metiloanhidro 1,1,n-trimetil-n-(3,3-difenilpropil)-2-aminoetilo-1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-piridino-3,5-dicarboxilato obtenido mediante dicho procedimiento.
JPS57171968A (en) 1,4-dihydropyridine derivative
BRPI0009229B8 (pt) processo de purificação de ácido láctico, em escala industrial.
DE69218330D1 (de) Verfahren zur Herstellung von an 4-Position substituierten 1,4-Dihydropyridinen
US5942624A (en) Manufacturing process for felodipine
CN1031221A (zh) (±)-顺或(±)-反-二氯菊酸的旋光拆分方法
RU2001113281A (ru) КОМПОЗИЦИЯ С ВЫСОКОЙ СТЕПЕНЬЮ ЧИСТОТЫ, СОДЕРЖАЩАЯ (7α,17α)-17-ГИДРОКСИ-7-МЕТИЛ-19-НОР-17-ПРЕГН-5(10)-ЕН-20-ИН-3-ОН
EP0398417A1 (en) Hydroxyfuranone preparation
BE1003199A5 (fr) Procede de preparation des derives de 1,4-dihydropyridine et a de nouveaux intermediaires utiles pour cette preparation.
KR930016399A (ko) 특정 1,4-디히드로피리딘-3,5-디카르복실산 에스테르, 그의 제조 방법 및 그의 제약 용도
KR870008872A (ko) 광활성 화합물의 제조방법
ATE66677T1 (de) Isomere von derivaten der dihydropyridin-3,5dicarboxyls|ureester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
IT1197800B (it) Processo per la sintesi di acidi carbossilici
TH30012A (th) กรรมวิธีสำหรับการเตรียมเลอคานิดิพันไฮโดรคลอไรด์
EP0445987A3 (en) Novel process for producing 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate-3-methyl ester-5-beta-(n-benzyl-n-methylamino)ethyl ester
ATE251099T1 (de) Verfahren zur gewinnung von 2,6- dimethylnaphthalen aus mischungen die es enthalten
CO5040220A1 (es) Un procedimiento para la preparacion de clorhidrato de lercanidipino
SU1737036A1 (ru) Способ извлечени монокристаллов YB @ С @ О @ из затвердевшего раствора-расплава
WO1995011908B1 (en) Novel phosphorus-containing spin-trap compositions
CN119019322A (zh) 一种高纯度的非对称1,4-二氢吡啶类化合物及其制备方法
KR970042532A (ko) 광학 활성 3-히드록시-1,5-벤조티아제핀 유도체 및 이것의 중간체의 제조 방법
DE69006210D1 (de) Verfahren zur abscheidung von distickstoffpentoxyd aus seiner lösung in salpetersäure.
Raev et al. Competitive reactions in the synthesis of nitrendipine
KR870004020A (ko) 디히드로피리딘 화합물 또는 그 염류의 제조 방법
ATE126190T1 (de) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5-